Activation of neurohumoral systems following acute myocardial infarction

J L Rouleau1, L A Moyé, J de Champlain

  • 1Cardiology Department, CHUS, Sherbrooke, Quebec, Canada.

Insights

Following a heart attack, persistent neurohumoral activation is common in patients with left ventricular dysfunction, even without overt heart failure. Measuring these neurohormone levels before hospital discharge may identify high-risk patients for targeted interventions.

Area of Science:

  • Cardiology
  • Neuroendocrinology
  • Internal Medicine

Background:

  • Patients with acute myocardial infarction (AMI) typically show neurohumoral system activation upon hospital admission.
  • This activation usually normalizes within 72 hours, except in cases of left ventricular dysfunction with or without heart failure.

Purpose of the Study:

  • To investigate persistent neurohumoral activation in patients post-myocardial infarction with left ventricular dysfunction but no overt heart failure at hospital discharge.

Main Methods:

  • The Survival and Ventricular Enlargement (SAVE) study measured plasma neurohormone levels (plasma renin activity, norepinephrine, arginine vasopressin, atrial natriuretic peptide) in 522 patients 12 days post-infarction.
  • All participants had left ventricular ejection fraction ≤40% but no overt heart failure.

Main Results:

  • Patients without overt heart failure but with left ventricular dysfunction exhibited elevated levels of all measured neurohormones compared to controls.
  • This indicates a subgroup with persistent neurohumoral activation at hospital discharge post-infarction.

Conclusions:

  • Persistent neurohumoral activation involves multiple systems in a significant subgroup of post-MI patients with left ventricular dysfunction.
  • Predischarge measurement of these neurohormonal levels could identify patients at higher risk for complications and potential beneficiaries of specific pharmacologic interventions.

Related Concept Videos

Sympathetic Signaling01:31

Sympathetic Signaling

Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Sympathetic Activation01:16

Sympathetic Activation

The sympathetic division can influence tissues and organs by releasing norepinephrine at peripheral synapses and distributing epinephrine and norepinephrine through the bloodstream. In times of crisis or stress, sympathetic activation occurs, which is regulated by sympathetic centers in the hypothalamus. As a result, sympathetic activation prepares the body for physical exertion, rapid ATP production, and heightened alertness, allowing individuals to respond effectively to challenging or...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...